Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samrat T Kundu

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Oncogene|August 6, 2020
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretionRakhee Bajaj, Samrat T Kundu, Caitlin L Grzeskowiak, et al.
International Journal of Cancer|August 30, 2008
Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasisSamrat T Kundu, Prajakta Gosavi, Nileema Khapare, et al.
Nature Communications|July 18, 2018
TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsinsSamrat T Kundu, Caitlin L Grzeskowiak, Jared J Fradette, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
PDK1 and YAP1/TEAD signaling drive acquired KRAS inhibitor resistance in KRAS-mutant non-small cell lung cancerAmrita Barua, Samrat T Kundu, Sofia G Garza, et al.
Plos One|June 16, 2012
Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasisNileema Khapare, Samrat T Kundu, Lalit Sehgal, et al.
Cell Reports|September 28, 2022
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasisRakhee Bajaj, B Leticia Rodriguez, William K Russell, et al.
Nature Communications|November 14, 2019
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancerRoxsan Manshouri, Etienne Coyaud, Samrat T Kundu, et al.
Science Translational Medicine|March 15, 2019
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.
Genes & Development|June 2, 2022
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8<sup>+</sup> cytotoxic T-cell responseSamrat T Kundu, B Leticia Rodriguez, Laura A Gibson, et al.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Oncogene|August 6, 2020
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretionRakhee Bajaj, Samrat T Kundu, Caitlin L Grzeskowiak, et al.
International Journal of Cancer|August 30, 2008
Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasisSamrat T Kundu, Prajakta Gosavi, Nileema Khapare, et al.
Nature Communications|July 18, 2018
TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsinsSamrat T Kundu, Caitlin L Grzeskowiak, Jared J Fradette, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
PDK1 and YAP1/TEAD signaling drive acquired KRAS inhibitor resistance in KRAS-mutant non-small cell lung cancerAmrita Barua, Samrat T Kundu, Sofia G Garza, et al.
Plos One|June 16, 2012
Plakophilin3 loss leads to an increase in PRL3 levels promoting K8 dephosphorylation, which is required for transformation and metastasisNileema Khapare, Samrat T Kundu, Lalit Sehgal, et al.
Cell Reports|September 28, 2022
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasisRakhee Bajaj, B Leticia Rodriguez, William K Russell, et al.
Nature Communications|November 14, 2019
ZEB1/NuRD complex suppresses TBC1D2b to stimulate E-cadherin internalization and promote metastasis in lung cancerRoxsan Manshouri, Etienne Coyaud, Samrat T Kundu, et al.
Science Translational Medicine|March 15, 2019
ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanismDavid H Peng, Samrat T Kundu, Jared J Fradette, et al.
Genes & Development|June 2, 2022
The microRNA-183/96/182 cluster inhibits lung cancer progression and metastasis by inducing an interleukin-2-mediated antitumor CD8<sup>+</sup> cytotoxic T-cell responseSamrat T Kundu, B Leticia Rodriguez, Laura A Gibson, et al.
Nature Communications|July 18, 2018
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancerCaitlin L Grzeskowiak, Samrat T Kundu, Xiulei Mo, et al.
Pageof 3